Nav: Home

New guidelines for life-saving blood transfusions based on Rutgers research

October 12, 2016

Most patients who need blood transfusions - including those who are critically ill - can be given blood when their hemoglobin drops to a lower level than practiced traditionally, according to AABB, a national association of blood banks that based its recommendation on research led by Rutgers University.

The new guidelines, published by The Journal of the American Medical Association (JAMA), were developed after Jeffrey L. Carson, professor of medicine at Rutgers Robert Wood Johnson Medical School, and an international team of scientists and doctors conducted comprehensive research using more than 60 years of red blood cell transfusion data and 31 clinical trials that examined outcomes of more than 12,500 individuals who received transfusion at lower (restrictive) verse higher (liberal) thresholds.

"Clinically, these results show that no harm will come from waiting to transfuse a patient until the hemoglobin level reaches a lower point," said Carson, first author of the paper and co-chair of the AABB guideline panel. "The restrictive approach is associated with reductions in blood use, blood conservation and lower expenses."

In the United States, an estimated 5 million people receive transfusions each year, according to the Centers for Disease Control and Prevention. They include surgery patients; accident, burn and trauma victims; mothers and babies during and after childbirth; and others whose blood counts reach low enough levels to threaten their lives. The guidelines recommend initiating a transfusion at a lower level than has been indicated in past practice.

AABB (formerly the American Association of Blood Banks) said based on the new evidence transfusions at a lower level are recommended for critical care patients as well as those undergoing orthopedic and cardiac surgery, and those with pre-existing cardiovascular disease. Further clinical trials are needed to determine whether heart attack patients with anemia or those with a bone marrow disorder benefit from transfusion at higher hemoglobin levels, Carson said.

"We are about to embark on a large international clinical trial supported by the NIH that will provide the evidence needed to determine the best course of action for patients who have had a heart attack," said Carson.

The new guidelines also include a second recommendation as a result of research that blood stored under standard conditions - up to 42 days - is just as safe as new blood which is less than 10 days old. According to Aaron Tobian, associate professor of pathology at Johns Hopkins University and co-chair of the AABB guidelines panel, "one of the biggest controversies in transfusion medicine is whether blood that is stored longer is harmful."

Carson, Tobian and colleagues from throughout the United States and Canada were involved in the guideline development that says transfusion medicine has significantly advanced the science in recent years and provides high quality evidence needed to make these recommendations.

Carson has been examining this issue for the past 25 years. In 2011, Carson's research published in the New England Journal of Medicine, which demonstrated the safety of few transfusions in the short term - 60 days- was one of the driving forces behind a change in blood transfusion practice nationally.

Guidelines are important because physicians performing surgeries and other procedures decide when a transfusion is needed, how much blood is needed based on how much blood the patient has lost and by closely watching vital signs such as low blood pressure.

"It is important for physicians and patients to know that these recommendations are based on high quality clinical evidence," said Carson. "We need to promote guidelines based on what science reveals."

Rutgers University

Related Heart Attack Articles:

Where you live could determine risk of heart attack, stroke or dying of heart disease
People living in parts of Ontario with better access to preventive health care had lower rates of cardiac events compared to residents of regions with less access, found a new study published in CMAJ (Canadian Medical Association Journal).
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Heart attack treatment might be in your face
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Study shows functional effects of human stem cell delivery to heart muscle after heart attack
Researchers delivered human stem cells seeded in biological sutures to the damaged heart muscles of rats following induced acute myocardial infarction and assessed the effects on cardiac function one week later.
Younger heart attack survivors may face premature heart disease death
For patients age 50 and younger, the risk of premature death after a heart attack has dropped significantly, but their risk is still almost twice as high when compared to the general population, largely due to heart disease and other smoking-related diseases The risk of heart attack can be greatly reduced by quitting smoking, exercising and following a healthy diet.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Attack Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.